Hands-on with the ECG feature in Apple Watch Series 4: taking an ECG is easy, but the ECG trace can only be viewed on the iPhone, not the watch itself
When Apple introduced the fourth iteration of its smartwatch, the big new selling point wasn't a feature we typically associate with a watch or any sort of smart device.
Context & Ripple Effects
This hands-on lands a week after the ECG feature went live in the US via watchOS 5.1.2, and three months after the FDA cleared the Series 4's heart monitoring based on Apple-backed studies — with the agency mandating that Apple label the risks of inaccurate readings. The practical takeaway from actually using it: capturing an ECG on the wrist is simple, but the trace itself lives on the iPhone, not the watch.
That split matters because it defines how Apple has architected its first regulated health feature — the watch as sensor, the phone as the record where results are stored and reviewed — and it sets up the tiering logic that shows up two years later when the cheaper Apple Watch SE ships without ECG support.
First-order effects
- Series 4 owners who take an ECG need their iPhone nearby to view the trace, making the phone a required part of the workflow rather than an optional companion.
- Apple's mandated risk labeling from the FDA clearance now sits alongside a real user experience, so accuracy caveats meet consumers at the moment they read their first result.
Second-order effects
- Health sensing becomes the segmentation lever inside Apple's own lineup: by 2020 the Apple Watch SE ships without ECG, letting Apple hold the feature back as the reason to buy up the line rather than a baseline capability.
Third-order effects
- If the pattern holds, clinically cleared sensors function as both a regulatory moat and a price-tier differentiator — rivals must clear the same bar to compete on health features, while Apple reserves them for higher-margin models.
- The watch-captures-phone-stores structure points toward the smartphone remaining the trusted repository for medical-grade consumer data, with wearables positioned as peripheral sensors feeding it.
The trend: Smartwatch makers are converting FDA-cleared health sensors into a competitive moat and a product-tier differentiator, with the phone serving as the trusted store for regulated readings.